Send Inquiry

Request To Call Back

Osimertinib Tablets 80mg

Price 160000 INR/ Box

Get a Price/Quote

MOQ : 2 Boxes

Osimertinib Tablets 80mg Specification

Feature
Third generation EGFR-TKI for T790M mutation-positive NSCLC

Weight
80mg per tablet

Color
Yellow

Composition
Each tablet contains 80mg Osimertinib

Lead Time
Ready stock or as per order schedule

Appearance
Film-coated tablet

Precautions
Non Prescription

Product Type
General Medicines

Ingredients
Osimertinib

Physical Form
Tablets

Treatments & Functions
Used in the treatment of non-small cell lung cancer (NSCLC)

Recommended For
Adults as prescribed by physician

Age Group
Adult

Dosage Guidelines
As directed by a healthcare professional; typically 80mg once daily

Quantity
1*10 Pieces

Packaging
Blister Pack

Storage Instructions
Keep Dry & Cool Place

Osimertinib Tablets 80mg Trade Information

Minimum Order Quantity
2 Boxes

Payment Terms
Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
10000 Boxes Per Week

Delivery Time
2 Week

Packaging Details
30 ML

Main Export Market(s)
South America, Africa, Asia, North America, Australia, Middle East, Central America, Western Europe, Eastern Europe

Certifications
WHO GMP COA FSC

About Osimertinib Tablets 80mg

Introducing Osimertinib Tablet 80mg, a ground-breaking development in oncology created exclusively to combat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). For those heroically fighting this powerful disease, it represents a ray of hope and provides a useful weapon in the fight for recovery. Patients can enjoy a newfound feeling of optimism as they set out on their path to recovery with every dosage of Osimertinib Tablet 80mg. Osimertinib, the active component in this pill, targets certain genetic abnormalities that fuel the development of cancer cells.

Product details

Strength	80mg
Packaging Size	1*10 Tablet
Form	Tablet
Prescription/Non prescription	Non Prescription
Treatment	LUNG CANCER
Manufacturer	Astrazeneca
Composition	OSIMERTINIB
Brand	Tagrisso 80mg

Targeted Lung Cancer Treatment

Osimertinib Tablets 80mg effectively target metastatic EGFR T790M mutation-positive NSCLC, offering patients a specialized therapy option. By inhibiting specific cancer pathways, this medication helps slow disease progression and may improve survival outcomes when other treatments are less effective.

Safe Administration and Storage

Take Osimertinib exactly as prescribed, with or without food, and store the tablets below 30C in a cool, dry place. Always check the packaging for expiry information and follow your healthcare providers guidelines to maximize safety and efficacy during treatment.

FAQs of Osimertinib Tablets 80mg:

Q: How should Osimertinib Tablets 80mg be taken for optimal benefits?

A: Osimertinib Tablets 80mg should be taken orally once daily, exactly as prescribed by your doctor. Swallow the tablet whole with water at the same time each day, with or without food, to maintain consistent blood levels.

Q: What is Osimertinib Tablets 80mg indicated for?

A: Osimertinib Tablets 80mg is indicated for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), as confirmed by appropriate diagnostic testing.

Q: When should I contact my healthcare provider while using Osimertinib Tablets 80mg?

A: You should contact your healthcare provider immediately if you experience symptoms such as severe diarrhea, persistent rash, new or worsening cough, shortness of breath, or signs of allergic reaction, as these may indicate serious side effects that require prompt attention.

Q: Where should Osimertinib Tablets 80mg be stored?

A: Store Osimertinib Tablets 80mg in a dry and cool place below 30C. Keep the medication in its original packaging and away from moisture, direct sunlight, and out of reach of children.

Q: What are the main benefits of taking Osimertinib Tablets 80mg?

A: The main benefits of Osimertinib Tablets 80mg include targeted action against cancer cells with EGFR T790M mutations, potentially better disease control in metastatic NSCLC, and an improved quality of life for suitable patients.

Q: Who should not use Osimertinib Tablets 80mg?

A: Osimertinib Tablets 80mg should not be used by individuals who are hypersensitive to Osimertinib or any excipients in the formulation. Always inform your doctor about any allergies before starting treatment.

Q: What precautions should I take while using Osimertinib Tablets 80mg?

A: Follow your prescribed dosage and schedule, have regular check-ups with your doctor, and notify them of any side effects. Do not use the product without a prescription, and always refer to the packaging for expiry and storage instructions.

Tell us about your requirement